Canada's Oncolytics Biotech Inc. changed its ticker symbol on the OTCQX market to ONCYD following a share consolidation.
The biopharmaceutical company said May 22 that it will consolidate shares on a 1-for-9.5 ratio in connection with an application to list on the Nasdaq Capital Market.
Alberta-based Oncolytics Biotech develops pharmaceutical products to treat cancer.
